Volker Laute
Overview
Explore the profile of Volker Laute including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoburg A, Niemeyer P, Laute V, Zinser W, Becher C, Kolombe T, et al.
Knee Surg Sports Traumatol Arthrosc
. 2022 Oct;
31(6):2482-2493.
PMID: 36269383
Purpose: To evaluate the safety and efficacy of matrix-associated autologous chondrocyte implantation (ACI) using spheroids in comparison to arthroscopic microfracture for the treatment of symptomatic cartilage defects of the knee....
2.
Hoburg A, Niemeyer P, Laute V, Zinser W, John T, Becher C, et al.
Orthop J Sports Med
. 2022 Jan;
10(1):23259671211053380.
PMID: 35071653
Background: Matrix-associated autologous chondrocyte implantation (ACI) is a well-established treatment for cartilage defects. High-level evidence at midterm follow-up is limited, especially for ACI using spheroids (spherical aggregates of ex vivo...
3.
Niemeyer P, Laute V, Zinser W, John T, Becher C, Diehl P, et al.
Knee Surg Sports Traumatol Arthrosc
. 2020 Jan;
28(4):1130-1143.
PMID: 31897548
Purpose: The aim of this study was to investigate the effect of product dose in autologous chondrocyte implantation (ACI) for the treatment of full-thickness cartilage defects of the knee and...
4.
Hoburg A, Niemeyer P, Laute V, Zinser W, Becher C, Kolombe T, et al.
Cartilage
. 2020 Jan;
13(1_suppl):437S-448S.
PMID: 31893951
Objective: Matrix-associated autologous chondrocyte implantation (ACI) and microfracture (MF) are well-established treatments for cartilage defects of the knee. However, high-level evidence comparing microfracture and spheroid technology ACI is limited. Design:...
5.
Niemeyer P, Laute V, Zinser W, Becher C, Diehl P, Kolombe T, et al.
Arch Orthop Trauma Surg
. 2019 Aug;
140(6):717-725.
PMID: 31451902
Aim: Cartilage defects of the patella are considered as a problematic entity. Purpose of the present study was to evaluate the outcome of patients treated with autologous chondrocyte implantation (ACI)...
6.
Niemeyer P, Laute V, Zinser W, Becher C, Kolombe T, Fay J, et al.
Orthop J Sports Med
. 2019 Jul;
7(7):2325967119854442.
PMID: 31317047
Background: Autologous chondrocyte implantation (ACI) and microfracture are established treatments for large, full-thickness cartilage defects, but there is still a need to expand the clinical and health economic knowledge of...
7.
Petersen W, Ellermann A, Henning J, Nehrer S, Rembitzki I, Fritz J, et al.
Arch Orthop Trauma Surg
. 2018 Sep;
139(2):155-166.
PMID: 30255369
Background: The use of an unloader brace is a non-surgical treatment option for patients with medial osteoarthritis (OA). However, many patients do not adhere to brace treatment, because of skin...
8.
Becher C, Laute V, Fickert S, Zinser W, Niemeyer P, John T, et al.
J Orthop Surg Res
. 2017 May;
12(1):71.
PMID: 28499391
Background: This study was conducted to assess the efficacy and safety of the three dose levels of the three-dimensional autologous chondrocyte implantation product chondrosphere® in the treatment of cartilage defects...
9.
Niemeyer P, Laute V, John T, Becher C, Diehl P, Kolombe T, et al.
Am J Sports Med
. 2016 May;
44(8):2005-14.
PMID: 27206690
Background: Although autologous chondrocyte implantation (ACI) has been established as a standard treatment for large full-thickness cartilage defects, the effect of different doses of autologous chondrocyte products on structural outcomes...